References
- Eberle FC, Mani H, Jaffe ES. Histopathology of Hodgkin's lymphoma. Cancer J 2009;15:129–137.
- Kuppers R, Zhao M, Hansmann ML, . Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993;12:4955–4967.
- Dutton A, Reynolds GM, Dawson CW, . Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR. J Pathol 2005;205:498–506.
- Bargou RC, Emmerich F, Krappmann D, . Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100:2961–2969.
- Skinnider BF, Elia AJ, Gascoyne RD, . Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2002;99: 618–626.
- Tuynman JB, Vermeulen L, Boon EM, . Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer. Cancer Res 2008;68:1213–1220.
- Nguyen DX, Chiang AC, Zhang XH, . WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009;138:51–62.
- Dosen G, Tenstad E, Nygren MK, . Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis. BMC Immunol 2006;7:13.
- Gelebart P, Anand M, Armanious H, . Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. Blood 2008;112:5171–5179.
- Derksen PW, Tjin E, Meijer H, . Illegitimate WNT signaling promotes proliferation of multiple myeloma cells. Proc Natl Acad Sci USA 2004;101:6122–6127.
- Morrison JA, Gulley ML, Pathmanathan R, . Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 2004;64:5251–5260.
- MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009;17:9–26.